ABSTRACT
Cytotoxic CD8
ϩ T cells are increasingly recognized as potential drivers of neuronal damage in various inflammatory CNS disorders of infectious, autoimmune, and paraneoplastic origin. Furthermore, a role for CD8
ϩ T cells has also been postulated in primary neurodegenerative central nervous system (CNS) disorders ( Fig. 1) . Examples for inflammatory disorders include multiple sclerosis (MS), viral encephalitides, progressive multifocal leukoencephalopathy (PML), RasmussenЈs encephalitis (RE), and paraneoplastic cerebellar degeneration (PCD). Examples for neurodegenerative disorders include amyotrophic lateral sclerosis (ALS), ParkinsonЈs disease (PD), and Alzheimer's disease (AD). It is believed that CD8 ϩ T cells can either directly target neurons and their neurites or lead to "collateral" neuronal damage following destruction of the myelin sheath and oligodendrocytes (ODCs) in both the CNS gray and white matter.
The relevance of CD8 ϩ T cells for the pathogenesis of MS has recently emerged. In acute and chronic inflammatory white-matter lesions, CD8
ϩ T cells by far outnumber CD4 ϩ T cells. While CD8 ϩ T cells can be found in the parenchyma, CD4
ϩ T cells display a more perivascular distribution (1, 2) . Conceptually, an immune attack against myelin components is considered the key pathogenetic event in MS. Accordingly, CD8
ϩ T cells are believed to recognize components of the myelin sheath and ODCs (3) . Indeed, they are frequently found in close apposition to ODCs and destroyed myelin. Further, they show oligoclonal expansions within the CNS, but also in cerebrospinal fluid (CSF) and in peripheral blood. Axonal damage in white-matter lesions correlates with the number of CD8 ϩ T cells (4, 5) and activated microglia/macrophages (6, 7) . Along with the finding that neurons and all other CNS cell types show profound MHC I expression in all types of inflammatory lesions (8) , these findings collectively suggest that in white-matter lesions, CD8
ϩ T cells could contribute as effector cells to the damage of both ODCs/myelin as well as axons. Gray-matter MS lesions display much lower T-cell infiltrates, possibly explainable by the far lower density of myelin/ODC antigen compared to white matter (9) . However, gray-matter lesions show a pronounced preponderance of CD8 ϩ T cells (10) . In these lesions, demyelination and ODC death are also accompanied by axonal and dendritic transections, reduced synaptic density, and apoptotic changes within neuronal perikarya (9, 11) . CD8 ϩ T cells also target neurons in various viral encephalitides, in which they are thought to either destruct the cell in order to clear the CNS parenchyma from the virus or help to maintain viral latency without destroying the infected neuron. Under these conditions, CD8
ϩ T cells accumulate in inflammatory lesions within the CNS white and gray matter and are found in close apposition to neurons. They exhibit substantial expression of the effector molecules perforin and granzyme B, demonstrating their activated phenotype (12, 13) . In addition to direct detrimental interactions of CD8 ϩ T cells with virus-infected neurons, a cytotoxic CD8 ϩ T-cell attack against virus-infected ODCs was recently reported to be associated with substantial collateral damage to neurons. In PML, latent infection of ODCs-and to a lesser extent astrocytes--by JC or SV40 virus is thought to become virulent upon breakdown of normal immune surveillance of the CNS (14, 15) . Inflammatory lesions accumulate CD8 ϩ T cells, which can be detected in close association to infected ODCs (16) , exhibit substantial MHC I expression (17) , and have been suggested to contribute to ODC killing for the sake of confining virus spread. In PML, destruction of neurons and their neurites accompanies acute demyelination and ODC death in the CNS gray and white matter (18) .
RE is considered to be a prime example of a CD8 ϩ T-cell-mediated, MHC I-restricted encephalitis with epilepsy. Patients suffer from intractable focal epilepsy, which is associated with spreading inflammation affecting only one hemisphere. The affected hemisphere is characterized by a pronounced T-cell infiltrate, predominantly by CD8 ϩ T cells, and a substantial loss of neurons and astrocytes. Approximately 7% of the CD8 ϩ T cells can be found in close apposition to MHC I (␤-microglobulin) expressing neuronal perikarya in the CNS gray matter (19) . Cytotoxic granules in T cells exhibit a polar orientation toward the neuronal plasma membrane in the absence of notable FasL expression. Neurons display impaired axonal transport as evident ϩ T cells in inflammatory and degenerative CNS disorders. A) Examples of human disorders with proven or assumed relevance of CD8 ϩ T cells for direct or collateral neuronal degeneration. In progressive multifocal leukoencephalopathy (PML; left) and multiple sclerosis (MS; middle), CD8 ϩ T cells target ODCs and the myelin sheath, whereas neurons (and astrocytes) are attacked in Rasmussen encephalitis (RE; right). B) Cytotoxic CD8 ϩ T cells either target neurons and their neurites directly or cause collateral neuronal damage following engagement with ODCs and the myelin sheath (or astrocytes) in gray-and white-matter areas or the CNS. Inset: interaction of CD8 ϩ T cells with their target cells on TCR (blue)-dependent recognition of antigen (black), presented in the context of MHC I molecules (red), and formation of the trimolecular complex leads to formation of the immunological synapse (IS), sealed by LFA-1:ICAM-1 complexes (yellow). CD8 ϩ T cells release perforin and granzymes (red circles) from cytotoxic granules into the IS via a regulated unidirectional secretory pathway (confined release) or liberate them via a constitutive multidirectional nongranule secretory pathway (nonconfined release). Nonconfined release together with leakage of perforin and granzymes from the IS promote collateral killing of neighboring cells. Activated CD8 ϩ T cells may also occupy Fas-receptors following the confined and nonconfined release of soluble s-FasL (yellow diamonds) or exposition of membrane-bound m-FasL on their surface. from accumulation of neurofilament within perikarya, as well as signs of apoptosis, including condensed nuclei and immunoreactivity for activated caspase-3 (19) . Notably, there were no comparable changes in ODCs and myelin sheaths (19) , but astrocytes have recently been reported to be a specific target of CD8 ϩ T cells, similar to neurons in RE (20) . CD8 ϩ T cells within the CNS, but also in the periphery, show clonal perturbations (21, 22) . CD8 ϩ T cells in RE lesions exhibit a restricted T-cell receptor (TCR) repertoire, suggesting that they have expanded from a few precursors locally responding to certain-yet unidentifiedantigenic epitopes in the CNS. Moreover, these clones persist over time in the CNS and partially in peripheral blood (21, 22) . The clonal persistence and reoccurrence of distinct, putative pathogenic CD8 ϩ T-cell clones correlate with disease activity in patients (unpublished results). Thus, in RE, CD8
ϩ T cells are considered key elements for the functional and structural impairment of neural tissue.
Loss of Purkinje neurons in PCD has been suggested to be mediated by cytotoxic CD8 ϩ T cells recognizing the onconeural antigen cdr2, which is expressed as a cytoplasmic antigen by tumor cells and cerebellar Purkinje neurons (23) (24) (25) (26) . Indeed, T-cell infiltration in the cerebellum can be detected in PCD (27, 28) , and Purkinje neurons are capable of expressing MHC I molecules (29) . This implies that they may present peptide epitopes derived from cdr2, rendering them targets of cdr2-specific cytotoxic CD8 ϩ T cells. However, the obligatory role of cdr2-specific CD8 ϩ T cells in PCD has recently been questioned (30, 31) . A CD8 ϩ T-cell-mediated cellular immune response against neuronal antigens expressed in malignant cells was also implied in other paraneoplastic neurological degenerations (32) .
Moreover, CNS infiltration and neuronal killing by the CD8 ϩ T cell is not only observed in inflammatory but also in various classic neurodegenerative disorders. For instance, in ALS (33) , most of the infiltrating lymphocytes in the precentral gyrus (34), the corticospinal tract, and anterior horns of the spinal cord (35) are cytotoxic CD8 ϩ T cells that display oligoclonal expansion as a likely consequence of their local antigen-driven activation (36) . In AD, significant numbers of cytotoxic CD8 ϩ T cells and MHC I-expressing cells are detected in a perivascular distribution in the diseased parietal cortex and hippocampus (37, 38) . In PD, the density of CD8 ϩ T cells exceeds that of CD4 ϩ T cells by a factor of 4 -5 in the midbrain substantia nigra (39, 40) . CD8 ϩ T cells are found in close contact with blood vessels or in direct vicinity of degenerating dopaminergic midbrain neurons and display uropodlike cytoplasmic extensions, suggestive of active migration through the CNS parenchyma (39) .
It has to be noted that the number of CD8 ϩ T cells found in degenerative CNS disorders is far lower than in primarily inflammatory disorders, and their true pathogenetic relevance (also in relation to CD4 ϩ T cells; refs. 39, 41) is not clear. Moreover, it remains to be determined whether infiltration of CD8 ϩ T cells into the CNS parenchyma in these conditions is primary, i.e., autoimmune in nature, or secondary, i.e., initiated by the degenerative process (which is far more likely).
CD8 ؉ T CELLS AND CNS TISSUE DESTRUCTION: POSSIBLE SEQUENCES OF EVENTS
Here, we focus on the role of effector CD8 ϩ T cells directed toward the complex of CNS neurons and ODCs and discuss molecular mechanisms of MHC I-dependent and -independent, direct and collateral killing, as well as functional impairment of neurons by CD8 ϩ T cells in various CNS diseases. The emerging role of neuronal MHC I molecules and their receptors in synaptic plasticity have recently been reviewed elsewhere (42, 43) and will not be a subject here. Moreover, the role of regulatory CD8 ϩ T cells (44) , B cells, and antibodies (45) , as well as effector and regulatory CD4 ϩ T cells (41, 46) , in CNS inflammation was recently reviewed elsewhere.
The occurrence of a CNS antigen-directed reaction by cytotoxic CD8 ϩ T cells requires the fulfillment of several prerequisites: peripheral priming of CD8 ϩ T cells within secondary lymphatic organs (e.g., cervical lymph nodes) must be followed by CNS invasion, reactivation, and clonal expansion of CNS antigenspecific CD8 ϩ T cells in inflammatory lesions. This should be accompanied by a breakdown of the immune-inhibitory environment of the CNS parenchyma, migration through the parenchyma, and formation of the immunological synapse (IS) upon cognate antigen recognition.
Initial CNS antigen transport, cross-presentation, priming, and clonal expansion of CD8 ؉ T cells in secondary lymphatic tissue: the afferent arm of the immune response Naive CNS antigen-reactive CD8 ϩ T cells need to be activated in secondary lymphatic tissue, i.e., the cervical lymph nodes (CLNs) by professional antigen-presenting cells (APCs) before they can enter the CNS (47) . Two mutually nonexclusive ways of antigen transport from the CNS to the CLNs following tissue damage have been suggested: CNS antigens may be drained to the CLNs, either passively with the CSF, which is in equilibrium with the extracellular space of the CNS gray and white matter, and lymphatics; or the antigen may reach the CLNs after uptake by professional APCs, such as dendritic cells (DCs), which reside in the perivascular spaces and can actively migrate to local lymph nodes (48) . APCs may acquire exogenous soluble and cell-bound antigens and may process and present them to naive CD8 ϩ T cells in the context of MHC I molecules, a process termed "cross-presentation" (reviewed in refs. 49, 50) . APCs usually present exogenous antigens on their surface in the context of MHC II molecules for the recognition by CD4 ϩ T cells. After endocytosis by various mechanisms, exogenous antigens are degraded within phagosomes, which then fuse with Golgi vesicles containing mature MHC II molecules. These MHC II molecules are synthesized in the endoplasmic reticulum (ER), where they are associated with the invariant-chain peptide (Ii), which prevents them from binding to endogenous antigens within the ER. MHC class II-invariant chain (MHC II-Ii) complexes move through the Golgi apparatus, where Ii is degraded to MHC class II-associated invariant-chain peptide (CLIP). CLIP is then removed from the MHC class II-CLIP (MHC-CLIP) complexes and exchanged for antigenic peptide. Antigen-loaded MHC II (pMHC II) complexes are transported to the cell surface to be presented to CD4 ϩ T cells (Fig. 2) . In contrast, endogenously synthesized proteins of either self or pathogen origin are usually degraded into peptides within the cytosol by the proteasome. Cytosolic peptides are then transported by the transporter associated with antigen presentation (TAP) complex into the ER, where they are loaded onto newly synthesized MHC I molecules. These pMHC I complexes are then transported via the Golgi apparatus to the cell surface to be presented to CD8 ϩ T cells (Fig. 2 ). Certain subsets of APCs, such as DCs and macrophages/microglia, are capable of cross-presenting exogenous antigens in the context of MHC I molecules to prime CD8 ϩ T cells. Among others, they use two major intracellular pathways, depending on where the antigen is degraded into peptides and where peptides are loaded onto MHC I molecules (49, 50) . Internalized exogenous antigen may be exported from the phagosome to the cytosol, where it is degraded by the proteasome. Peptides are then transferred from the cytosol into the ER via TAP, where they associate to MHC I molecules and are targeted to the surface membrane. Alternatively, antigen may be degraded by proteases within the phagosome itself. MHC I molecules are then recycled from the surface membrane or sorted from the ER to phagosomes, where they acquire peptides and are delivered to the surface membrane (49, 50) (Fig. 2) .
However, cross-presentation of CNS antigens per se usually results in CD8 ϩ T-cell tolerance (51) unless APCs are "licensed" by antigen-specific CD4 ϩ T cells (52) , favoring activation and expansion of CD8 ϩ T cells (53) . Access of soluble antigen to the cross-presentation pathway is enhanced with increasing amounts of antigen provided by CD8 ϩ T-cell-mediated tissue destruction (54) and in the presence of high CD8 ϩ T-cell precursor frequencies (55) .
Indeed, intracerebral injection of MHC I-deficient cells expressing a membrane-bound antigen led to phagocytosis by DCs, cross-priming in cervical lymph nodes, and homing to the CNS of antigen-specific CD8 ϩ T cells (56) . Cross-presentation depended on licensing of APCs through induction of costimulatory CD40 expression by CD4 ϩ T cells (57) . Likewise, mice implanted with murine glioma cells lacking MHC I molecules necessary to directly present tumor-derived antigen in situ, demonstrated cross-priming and accumulation of functional tumor-specific CD8 ϩ T cells within the CNS, implying a role for cross-presentation in priming and retention of fully differentiated CD8 ϩ T cells in the CNS (58, 59) . This pathway requires an initial destructive event within the CNS, such as infection, tumor growth, ischemia, microtrauma, or "spontaneous" degeneration to liberate CNS antigen and will ϩ T cells (green). After endocytosis by various mechanisms, exogenous antigens are degraded within phagosomes, which then fuse with Golgi vesicles containing mature MHC II molecules. These MHC II molecules are synthesized in the endoplasmic reticulum (ER), where they are associated with the invariant-chain peptide (Ii), which prevents them from binding to endogenous antigens within the ER. MHC class II-invariant chain (MHC II-Ii) complexes move through the Golgi apparatus, where Ii is degraded to MHC class II-associated invariant-chain peptide (CLIP). CLIP is then removed from the MHC class II-CLIP (MHC-CLIP) complexes and exchanged for antigenic peptide. Antigen-loaded MHC II (pMHC II) complexes are transported to the cell surface to be presented to CD4 ϩ T cells. Middle: endogenously synthesized proteins of either self or pathogen origin are usually degraded into peptides within the cytosol by the proteasome. Cytosolic peptides are then transported by the transporter associated with antigen presentation (TAP) complex into the ER, where they are loaded onto newly synthesized MHC I molecules (blue). These pMHC I complexes are then transported via the Golgi apparatus to the cell surface to be presented to CD8 ϩ T cells (blue). Left: certain subsets of APCs, such as DCs and macrophages/microglia, are capable of cross-presenting exogenous antigens in the context of MHC I molecules to prime CD8 ϩ T cells. Internalized exogenous antigen is exported from the phagosome to the cytosol, where it is degraded by the proteasome. Peptides are then transferred from the cytosol into the ER via TAP, where they associate with MHC I molecules and are targeted to the surface membrane. Alternatively, antigen may be degraded by proteases within the phagosome itself. MHC I molecules are then recycled from the surface membrane or sorted from the ER to phagosomes, where they acquire peptides and are delivered to the surface membrane. then sustain and amplify ongoing CNS damage by CD8 ϩ T cells. In contrast, naive CNS antigen-reactive CD8 ϩ T cells could also be primed in the periphery by APCs following cross-presentation of tumor-or pathogen-derived antigens with sufficient structural or sequence similarity or even identity to CNS antigens, without the requirement of an initial destructive process within the CNS (molecular mimicry/identity). When transgenic mice expressing the nucleo-or glycoprotein of lymphocytic choriomeningitis virus (LCMV) as self in ODCs were infected with LCMV in the periphery but not in the CNS, a chronic inflammation of the CNS accompanied by up-regulation of MHC I and II molecules in the target tissue occurred after clearance of the virus form the periphery. A second LCMV infection led to enhanced CNS pathology, characterized by loss of myelin and ODCs and clinical motor dysfunction (60) . Accordingly, in mice expressing ovalbumin (OVA) as selfantigen in neurons, infection with attenuated listeria monocytogenes-releasing OVA induced an atactic-paretic neurological syndrome after bacterial clearance from the brain. This syndrome was mediated by CD8 ϩ T cells, which specifically induced apoptosis in MHC I-expressing neurons in vivo (61) . In both cases, transgenetic expression of an pathogen-derived antigen as self in CNS cells resulted in their destruction by antigen-specific CD8 ϩ T cells activated on infection. Likewise, following neonatal infection of mice with an attenuated LCMV, this virus failed to induce virusantigen-specific CD8 ϩ T-cell response. However, it persisted in neurons and rendered them selective targets of virus-specific CD8 ϩ T cells activated on reinfection of these adult mice with wild-type LCMV. Encephalitis in these mice was mediated by virus-specific CD8 ϩ T cells targeting an epitope shared by both viruses (62) .
Further potential mutually nonexclusive mechanisms of pathogen-dependent activation of CNS-antigen reactive CD8 ϩ T cells include coactivation of bystander CD8 ϩ T cells, intramolecular and intermolecular epitope spreading during the course of CNS inflammation, and the presentation of cryptic antigen (reviewed in ref. 63) .
CNS invasion of cytotoxic CD8
؉ T cells, local reactivation, and clonal expansion: the efferent arm of the immune response T-lymphocyte trafficking to the CNS has predominantly been studied in CD4 ϩ T cells, as this subset makes up Ͼ80% of the leukocytes in the CSF under physiological conditions and is thought to exert normal immunosurveillance of CNS parenchyma. Following antigen priming in lymphoid organs, CD4
ϩ T memory cells can travel to the CSF spaces by different routes: They can permeate through the fenestrated endothelium of the choroid plexus stroma, migrate through the stromatal core, and finally enter the ventricular CSF following permeation through the epithelial wall of the choroid plexus. Moreover, CD4
ϩ T memory cells can extravasate through the postcapillary venules into the CSF of the subarachnoidal and perivascular space (64) . To enter the CNS parenchyma, CD4
ϩ T memory cells need to reencounter their cognate antigen presented in the context of MHC II molecules by APCs residing in the perivascular and subarachnoidal spaces, become reactivated and traverse the glia limitans built by the endfeet of perivascular astrocytes (65) . This implies that only reactivated CNS antigen-specific CD4 ϩ T cells will enter the CNS parenchyma in the presence of their cognate antigen either within the CSF or the CNS parenchyma itself. Indeed, MHC II expression by perivascular APCs is required and sufficient to fully develop neurological disease induced by adoptive transfer of activated CNS-antigen-reactive CD4 ϩ T cells in mice, demonstrating that penetration of CD4 ϩ T cells into the CNS parenchyma critically depends on preceding MHC II-restricted cognate antigen recognition (66 -68) .
Following adoptive transfer and active immunization, CNS-antigen-reactive CD8 ϩ T cell can enter the CNS similar to CD4 ϩ T cells (69 -71) . Their pathogenic relevance has meanwhile been shown in various other models of neuroinflammation, both primary inflammatory or degenerative in nature (72, 73) . However, mechanistic insights into how CD8 ϩ T cells enter the CNS parenchyma was lacking until recently. Galea and coworkers demonstrated, that on intrastriatal injection of the hemagglutinin (HA)-peptide antigen into CL4 mice (which bear high-avidity HA-specific TCR-transgenic CD8 ϩ T cells), these T cells only infiltrate the brain when and where their cognate antigen is present in the CNS. This antigen-dependence of CD8 ϩ T-cell traffic to the CNS was not due to presentation by perivascular APCs but depended on constitutive and inducible luminal expression of MHC I molecules by cerebral endothelial cells (74) . Notably, CD8
ϩ T cells infiltrating the CNS after intrastriatal injection of antigen were not fully activated, as shown by a lack of expression of cytotoxic granule molecules and a lack of tissue damage. In contrast, expression of cytotoxic molecules and axonal/myelin damage could be induced by active peripheral immunization with HAantigen or passive transfer of in vitro-activated HAreactive CD8 ϩ T cells (74) . Hence, infiltration of both CD4 ϩ and CD8 ϩ T cells into the CNS parenchyma after priming in local lymph nodes seems to be an antigen-dependent process. However, the site of antigen presentation seems to differ for both T-cell subsets.
Breakdown of the immune-inhibitory properties of the CNS parenchyma: up-regulation of MHC I expression and down-regulation of T-cell-inhibitory molecules on target cells
Besides special characteristics of the afferent and efferent arms of the immune response in the CNS, the immune-inhibitory environment of the CNS parenchyma itself represents another aspect of CNS-directed immune responses. Generally speaking, the CNS parenchyma possesses immune-inhibitory properties, contributing to the view of the CNS as an immunopriviledged site (48) (76) . This process does not depend on antigen recognition by or the activation state of the T cell (77) . Thus, the Fas-FasL system represents a rather unselective immunological barrier for CD8 ϩ T-cell-mediated killing in the CNS (78). Moreover, CNS cells are capable of expressing coinhibitory members of the B7 family, which are up-regulated under inflammatory conditions and interact with programmed-death receptor-1 (PD1) on T cells in order to inhibit activation and cytokine secretion (79 -81) . Both neurons (82) and astrocytes (83) 
In addition to these cell-contact-dependent inhibitory mechanisms of adaptive T-cell counterbalance, there is also profound humoral control of T-cell function in the CNS. Encephalitogenic T cells are able to induce indolamine 2,3-dioxygenase expression in microglia (84) , resulting in the release of certain tryptophan metabolites, kynurenines, which, in turn, dampen proliferation and cytokine release of both CD8 ϩ and CD4 ϩ T cells (85) . Activated microglia are capable of locally cross-presenting exogenous CNS antigens to CD8 ϩ T cells upon CNS damage and thus may initiate and propagate cytotoxicity by CD8 ϩ T cells (86, 87) . Under noninflammatory circumstances, however, microglia activationincluding MHC I-restricted antigen presentation-is tightly controlled, predominantly by the integrity of CNS neurons: neurons constitutively express both CD200 and CD47, which interact with their receptors CD200R and signal-regulatory protein ␣ on microglial cells. These signals keep them in a ramified, inactivated state, preventing inflammatory effector functions, phagocytosis, and antigen presentation (88 -91) . Moreover, electrically active neurons suppress antigen presentation by microglia, in part, by tonic secretion of neurotrophins binding to microglial neurotrophin receptors (92) . Neurons also secrete the chemokine fractalkine and CD22, both of which attenuate microglial activity by binding to their receptors, CX3CR1 and CD45 (93, 94) . Likewise, MHC I expression and antigen presentation by target cells, i.e., glia and neurons themselves, are also virtually absent under noninflammatory conditions (95) .
Hence, CD8 ϩ T cells homing to the intact CNS face a tonically immune-inhibitory environment, a lack of local antigen presentation, and restimulation by microglia and the virtual absence of MHC I expression on target cells. However, regardless of the initiating event, pathological conditions obviously overcome the immunosuppressive CNS environment. Primary neuronal and oligodendroglial damage leads to activation of surrounding microglia, their migration to the site of damage, release of proinflammatory cytokines such as interferon-␥ (IFN-␥) and tumor necrosis factor-␣ (TNF-␣), phagocytotsis, and antigen presentation. The presence of a proinflammatory milieu (IFN-␥) together with electrical silencing of injured neurons permits the
ϩ T cells. Moreover, activated microglia/ macrophages suppress neuronal excitability by enhancing potassium outward currents mediated by delayed rectifier K ϩ channels (98) , potentially leading to enhanced MHC I expression. CD8 ϩ T cells, in turn, release proinflammatory cytokines and are capable of electrically silencing neurons and may thus themselves enhance MHC I expression and antigen presentation in the CNS parenchyma (99) .
Hence, under inflammatory circumstances, breakdown of the immune-inhibitory properties of the CNS parenchyma facilitates invasion, migration, antigen recognition, and target-cell killing by CD8 ϩ T cells.
Migration of CD8 ؉ T cells through the CNS parenchyma: random walk in search of antigen-presenting target cells

Activated CNS-antigen specific CD8
ϩ T cells migrate through the CNS parenchyma and screen for the presence of their cognate antigen presented by MHC I molecules. Current experimental evidence regarding the migratory behavior of activated CD8 ϩ T cells in target tissue and interaction with MHC I-expressing target cells largely comes from in vivo 2-photon-microscopy studies on solid tumors (100). In contrast, CD4 ϩ T-cell migration has been extensively investigated in models of autoimmune CNS inflammation (101) .
Real-time CD8 ϩ T-cell migratory behavior has been investigated with in vitro-activated OVA-specific CD8 ϩ T cells adoptively transferred into mice carrying subcutaneously implanted thymomas, either expressing or lacking the cognate OVA antigen (102, 103) . In antigenexpressing target tissue, CD8 ϩ T cells showed either motile or stationary behavior. Stationary CD8 ϩ T cells were engaged in long-lasting interactions with target cells (102) , reflecting the delivery of a stop signal to migrating T cells (104) . At later time points, coinciding with caspase-3 activation and apoptotic target cell death, CD8 ϩ T cells resumed and retained high motility, engaging in repetitive short-term interaction with target cells in search for another target. Between targetcell contacts, migration of CD8 ϩ T cells exhibited characteristics of a random-walk process (i.e., a linear relationship between the mean T-cell displacement and the square root of time), maximizing the probability of further target-cell contacts. In contrast, in the absence of the cognate antigen, CD8 ϩ T cells initially migrated at high velocities but subsequently slowed down with an increasing number of nonmigratory cells. Thus, cognate signals delivered by the TCR to infiltrating CD8 ϩ T cells were considered to be required to maintain high motility of primed CD8 ϩ T cells in target tissues (102) . In addition to interacting with target cells, migrating CD8 ϩ T cells made intermediate contacts with macrophages/microglia, pointing toward the potential importance of repetitive antigen cross-presentation for sustained migration and target-cell killing by CD8 ϩ T cells (102) .
We investigated the migratory and interactive behavior of activated OVA-specific CD8 ϩ T cells transferred into hippocampal slice cultures using 2-photon microscopy (ref. 105 ϩ T-cell motility in an antigen-dependent manner, TCR signals therefore maximize killing efficiency of these cells.
Engagement of the CD8
؉ T cell with its target cell: formation of the IS TCR signaling upon recognition of the appropriate antigen in the context of MHC I molecules during engagement of activated CD8 ϩ T cells with their target cells leads to the redistribution and accumulation of cytoskeletal, adhesion, costimulatory, and signal transduction molecules of the CD8 ϩ T cell toward the cell-cell interface, resulting in the formation of the IS (Fig. 1B, inset) (106) . Initially, signaling molecules (TCR complex, CD8 coreceptor, downstream signaling molecules) and adhesion molecules (LFA-1, ICAM-1) cluster at the center of the contact site and then segregate to form a highly ordered structure with signaling molecules in the center [central supramolecular activation complex (cSMAC), "signaling domain"]. In addition, adhesion proteins form a concentric ring around them [peripheral supramolecular activation complex (pSMAC)], excluding other proteins from the contact site, that form the distal supramolecular activation complex (dSMAC). Moreover, the microtubule-organizing center (MTOC) polarizes toward the contact site, allowing secretory lysosomes to move vectorially along the microtubules toward the T-cell plasma membrane, with which they dock, fuse, and release their cytotoxic effector molecules into the "synaptic cleft" ("secretory domain").
CD8 ϩ T-cell-mediated cytotoxicity is predominantly mediated via two largely independent pathways: perforin-dependent delivery of several granzymes into the target cell and interaction of CD8 ϩ T-cell-derived Fasligand with the Fas-receptor on the target cell surface (107, 108) . Granule cytotoxicity occurs by liberation of perforin together with a variety of granzymes. Perforin alone can lead to rapid necrosis of the target cell within minutes through the formation of large unselective transmembrane pores, leading to rapid swelling and rupture of the cell membrane (109) . Alternatively, perforin mediates the trafficking of granzymes into the target cell, promoting apoptosis within a few hours. The exact mechanisms are still somewhat elusive (109, 110) . Target-cell apoptosis may also occur through the ligation of cell-death receptors (e.g., FasL/Fas; ref. 75) . Moreover, CD8
ϩ T cells are able to contribute to inflammatory tissue damage by the secretion of potentially toxic cytokines, such as IFN-␥ and TNF-␣ (111) .
The use of either the FasL-Fas or the perforingranzyme pathway of CD8 ϩ T cells depends on the strength of the antigen signal delivered to the CD8 ϩ T cell (i.e., the number of pMHC I complexes and the affinity of the TCR complex, including coreceptors to the pMHC I complex). This eventually results in different intracellular calcium signals in T cells: low-antigen signals favor killing via the FasL-Fas pathway, whereas high-antigen signals promote killing via perforin-granzyme exocytosis (112) (113) (114) . Given very high TCRpMHC I-affinities, the minimum number of pMHC complexes per target cell required to elicit a cytotoxic T-cell response can be as low as 1-3 (114, 115) , which is a negligible fraction in relation to the total number of MHC molecules on the target-cell surface membrane. However, in the case of low-TCR-pMHC affinities, several thousand pMHC I-complexes per target cell are needed to elicit a cytotoxic T-cell response (116) . In vitro, activated CD8 ϩ T cells are able to kill cultured neurons (117) , either by the perforin-granzyme pathway (118, 119) or the FasL-Fas pathway (120, 121) . Interestingly, killing by the FasL-Fas pathway by activated CD8 ϩ T cells may occur independently from specific target antigen presentation (75, 120) .
Mechanisms of collateral damage by CD8
؉ T cells: "leaky" synapses and nonconfined release of effector molecules during serial and simultaneous killing
The formation of ringlike structures by adhesion-molecule complexes during formation of the IS has been suggested to tightly seal the synaptic cleft, thereby assuring high concentrations of effector molecules and limit their spillover to neighboring cells (106, 122) . However, it was shown that on CD8 ϩ T cell-target cell interaction, CD8 ϩ T-cell cytotoxicity can precede formation of a stable IS (123) and can happen without stable formation of ringlike structures by LFA-1:ICAM-1 complexes at all (114) , thereby favoring the leakage of effector molecules out of the synaptic cleft into the surrounding space.
In the inflamed CNS, the scenario could be as follows. Facing excess amounts of target cells in the inflamed tissue, invading CD8 ϩ T cells (which might be present in limited numbers) probably use two mutually nonexclusive strategies to increase killing efficiency: sequential and simultaneous killing of several target cells, both of which bear the risk of spatially nonconfined release of effector molecules and collateral cell death (Fig. 1B) . Cytotoxic CD8 ϩ T cells are capable of sequential target cell killing in vitro (124 -126) and in vivo (103) and have thus been termed "serial killers." It has been proposed that after disengagement of the CD8 ϩ T cell from its target cell, cytotoxic effector molecules that have not been endocytosed by the target cell may leak out of the former IS (127) . Furthermore, it was demonstrated that during serial killing, repetitive TCR triggering leads to the resynthesis of both perforin and granzymes, which are either stored in releasable cytotoxic granules for regulated unidirectional secretion into the IS or are released via a constitutive multidirectional nongranule secretory pathway (128) . This pathway largely lacks the spatial restriction of granule-mediated exocytosis and thus results in substantial bystander killing (129) . In addition, granule exocytosis into the extracellular space can also be triggered in the absence of a target cell by interaction of the CD8 ϩ T cell with components of the extracellular matrix, which is assumed to facilitate T-cell migration through target tissues (127, 130) . CD8 ϩ T cells are capable of simultaneously interacting with several target cells (123, 131, 132) and killing them by polarizing lytic granules toward multiple opposing target-cell interfaces (123, 131) . This simultaneous killing occurs irrespective of the strength of the antigen stimulation delivered to the CD8 ϩ T cell by each target cell. Thus, this mechanism might enhance killing efficiency but abet killing of bystander cells (123) . Moreover, bystander cells may, in principle, acquire low-antigen potential by intercellular antigenpeptide transfer through gap-junction channels (133, 134) or extracellular transloading of antigen peptides (74) from MHC I molecules of target cells onto those of bystander cells on destruction of the target cell.
In line with the concept of collateral killing by CD8 ϩ T cells, the adoptive transfer of in vitro primed CD8 ϩ T cells targeting either physiological or neoself-antigen transgenetically expressed in distinct non-neuronal CNS cell compartments resulted in profound collateral neuronal and axonal damage in a number of experimental systems (70, 71, 135, 136) . We transferred activated OVA-specific CD8 ϩ T cells into brain slices from mice selectively expressing OVA as a cytosolic neoself-antigen in ODCs and studied mechanisms and kinetics of oligodendroglial and collateral neuronal apoptosis in the neocortex and hippocampus. Within both gray-matter areas, a single CD8 ϩ T cell caused simultaneous caspase-3 activation in ϳ30 ODCs and 10 neurons in a strictly antigen-dependent manner. Collateral apoptosis of neurons was likely due to a spillover of perforin and granzymes, either from the CD8 ϩ T cell itself or the IS that it selectively formed with antigenpresenting ODCs (ref . 137 and unpublished results) .
Moreover, such spatially extended release of cytotoxic effector molecules into the extracellular space may even result in the accumulation of these molecules in the CSF during various inflammatory CNS disorders (138, 139) and the blood during several peripheral inflammatory diseases (140) in humans. Thus, spillover of cytotoxic effector molecules from leaky IS and nonconfined release by CD8 ϩ T cells themselves during serial and simultaneous killing promotes collateral neuronal damage in a variety of CNS disorders, in which ODCs (and astrocytes) are the genuine target cells.
TOPOLOGICAL PATTERN OF CD8
؉
T-CELL-MEDIATED DESTRUCTION OF CNS NEURONS: POSSIBLE CONSEQUENCES OF CD8 ؉ T CELL-NEURON INTERACTIONS
The possible consequences of CD8 ϩ T cell-target cell recognition in the CNS for neuronal cell death certainly depends on the site of interaction (Fig. 1B) . Anatomically, one would assume that CD8 ϩ T cellneuron interactions would result in neuronal cell death and damage to dendrites in CNS gray mater. In the CNS white matter, axonal damage would be expected. In the CNS white matter, axons can either be direct or indirect targets of CD8 ϩ T cells, depending on the cellular expression of the target antigen. In both cases, focal attack by cytotoxic CD8 ϩ T cells would result in intra-axonal Ca 2ϩ accumulation and activation of Ca 2ϩ -dependent proteases (141, 142) . Together with the delivery of granzymes into the axoplasma and subsequent activation of caspases (143) , this will cause proteolytic degradation of components of the axonal cytoskeleton, leading to acute impairment of axonal transport with focal accumulation of transported proteins and organelles. This process might potentially be reversible (144) . Together with the acute disturbance of axonal osmotic volume regulation due to the massive ion influx into the small volume of the axonal cytoplasma (145) , this leads to the formation of focal swellings (spheroids, varicosities, beads) (146) . During sustained interaction, irreversible complete axonal transection with formation of proximal and distal end bulbs (146) can also occur, a process that is followed by Wallerian degeneration (147) . Retrograde degeneration of the proximal stump and transmission of the cell death signal may occasionally result in subsequent apoptotic degeneration of the neuronal cell body (148, 149) . Moreover, anterograde degeneration of the distal axons may also lead to apoptotic degeneration of target neurons in gray-matter areas remote from the site of transection.
Indeed, axonal damage was observed as a consequence of direct antigen expression by neurons (61) and ODCs (71, 136) (150); blocking of CD8 ϩ T cells in this model preserved axons without changing the level of demyelination (151) . Moreover, despite unchanged demyelination, virus-infected mice deficient for perforin but not those deficient for FasL or Fas showed axonal preservation (152, 153) . In principle, these mechanisms of axonal damage should also apply for CD8 ϩ T-cell-mediated destruction of dendrites in the CNS gray matter (154) .
Although neuronal somata have been suggested to be relatively protected against CD8 ϩ T-cell cytotoxicity through the inhibition of granule exocytosis by neuronal FasL, interacting with T-cell Fas receptors (155) , CD8 ϩ T cells may directly attack neuronal cell bodies and induce cell death in the CNS gray-matter areas (61) . Moreover, adoptive transfer of in vitro primed CD8 ϩ T cells targeting either physiological or neoself antigen transgenetically expressed in ODCs or astrocytes resulted in profound collateral neuronal cell death in gray-matter areas (70, 135) .
Hence, neuronal perikarya, as well as neurites, may be damaged by CD8 ϩ T cells in inflammatory lesions of the CNS gray and white matter.
DIRECT AND COLLATERAL EFFECTS OF CD8
؉
T CELLS ON NEURONAL EXCITABILITY: FUNCTIONAL IMPAIRMENT BY ELECTRICAL SILENCING PRECEDES NEURONAL CELL DEATH
Besides the induction of cell death, effector molecules of cytotoxic CD8 ϩ T cells (and possibly also cytotoxic CD4 ϩ T cells; refs. 41, 156) are capable of disturbing electrical signaling in excitable target and bystander cells following a confined and nonconfined release. Whereas experimental evidence on the effects of these molecules on the electrical excitability of neurons is thus far sparse, this was extensively studied in ventricular cardiomyocytes (157, 158) : Within minutes, purified perforin or lytic granules exposed to ventricular cardiomyocytes cause a depolarization of the resting membrane potential and a decrease of the action potential amplitude and duration, and induce oscillations of the membrane potential. These effects are mediated by perforin per se and cannot be induced by granzymes alone (159, 160) . Perforin monomers assemble to form large, unselective polyperforin channels in the targetcell membrane. These channels exhibit almost no voltage-dependent gating transitions, and a high open probability together with a single channel conductance of 1-2 nS. Thus, large transmembrane ion fluxes are favored, as shown in lipid bilayer membranes and intact cells (161, 162) . These ion fluxes lead to the dissipation of transmembrane electrochemical ion gradients and an intracellular Ca 2ϩ overload, and finally result in total electrical silence and collapse of the target cell. Indeed, purified perforin and lytic granules induce voltageindependent single channels with a mean open time of several seconds, a reversal potential of Ϫ8.2 mV, and a mean conductance of 860 pS in the plasma membrane of whole cell patch-clamped ventricular cardiomyocytes (159, 160) . After 2 h, these cells exhibit an intracellular Ca 2ϩ concentration in the micromolar range. This is most likely due to transmembrane Ca 2ϩ entry through perforin pores rather than through voltage-gated Ca 2ϩ channels or by Ca 2ϩ liberation from intracellular stores (163) . Notably, perforin pore formation and Ca 2ϩ overload can be inhibited by CoCl 2 (163) .
Exposition with activating anti-Fas receptor antibodies, as well as conjugation with perforin-deficient CD8 ϩ T cells, also induced pronounced perturbation of electrical signaling in ventricular cardiomyocytes: the resting membrane potential was depolarized, and the action potential amplitude was reduced. The action potential duration was prolonged, a finding in marked contrast to the effects of perforin (164) . Fas-receptor activation results in activation of the phospholipase C and generation of 1,3,4-inositol-trisphosphate (IP 3 ), which, in turn, triggers the release of Ca 2ϩ from intracellular stores. The resulting intracellular Ca 2ϩ accumulation caused a pronounced attenuation of transient outward K ϩ currents and an enhancement of L-type Ca 2ϩ currents and thus prolonged the action potential duration, allowing for augmented transmembrane Ca 2ϩ entry. This is evident as electrophysiological effects of Fas-receptor activation can be mimicked by intracellular application of IP 3 and can be abrogated by blocking phospholipase C or the IP 3 receptor channel or by store depletion (164, 165) . Together, these effects result in an intracellular Ca 2ϩ overload of ventricular cardiomyocytes within few hours after Fasreceptor activation.
Given the fact that most of the subcellular elements required for CD8 ϩ T-cell-mediated impairment of electrical excitability in cardiomyocytes are also present in neurons (166) , it seems conceivable to assume that similar mechanisms will also lead to perturbation of neuronal excitability on direct and indirect CD8 ϩ T cell-neuron interactions. Indeed, using whole-cell patchclamp recordings from MHC I-expressing, OVA-peptideloaded hippocampal neurons, we could demonstrate an immediate impairment of electrical signaling on direct cell-cell contact with activated antigen-specific CD8 ϩ T cells. Electrical silencing was due to massive shunting of the membrane capacitance following insertion of CD8 ϩ T-cell-derived channel-forming perforin, which was paralleled by an increase of intracellular Ca 2ϩ levels. Thus, perforin-dependent electrical silencing is an immediate consequence of MHC I-restricted interaction of CD8 It is important to note that cytotoxic effector molecules are released not only by CD8 ϩ T cells but also by a distinct subset of cytotoxic CD4 ϩ T cells (41, 156) , which display very similar gene expression pattern on activation (167) . Surprisingly, intracellular Ca 2ϩ oscillations and final stable Ca 2ϩ overload of neurons were found to be induced by such activated cytotoxic CD4 ϩ T cells independent of their target antigen within intact hippocampal slices (168) . Intracellular Ca 2ϩ accumulation induced by cytotoxic CD4 ϩ T cells was prevented by concanamycin A, a selective inhibitor of the vesicular H ϩ -ATPase, which prevents proper acidification of granules and thereby inactivates perforin (169 -171) .
This suggests that neuronal cell death by these cytotoxic CD4 ϩ T cells results from perforin-mediated transmembrane Ca 2ϩ entry. However, in this setting, several inhibitors of NMDA-and AMPA/kainate-glutamate receptors were equally capable of preventing intracellular Ca 2ϩ overload and neuronal cell death (168) . This is in line with the finding that intracellular Ca 2ϩ overload and death of cerebellar granule cells induced by purified cytotoxic granules can be reduced by 65-80% by antagonists of NMDA receptors. Thus, one has to assume that the NMDA receptor complex is involved in the effects of purified cytotoxic granules on neurons (118) . The NMDA receptor may be activated by extracellular glutamate released by the T cell (172) or the neuron itself. The latter could work through vesicular or nonvesicular mechanisms (173) following initial depolarization and relief of the Mg 2ϩ block of NMDA receptor channels by perforin or FasL. In turn, activation of ionotropic glutamate receptors is known to increase MHC I expression in neurons by a NF-Bdependent mechanism (174), thereby potentially amplifying antigen presentation and cytotoxic effects by CD8 ϩ T cells. In addition, MHC I protein complexes per se undergo voltage-dependent conformational changes on alteration of the membrane potential (175) , which affect the efficiency of antigen presentation, as well as target cell recognition and killing by CD8 ϩ T cells (176) . These findings illustrate the complexity of the molecular signaling mechanisms involved in cytotoxic T cell-neuron interactions.
It is important to note that cytokines are released from T cells in a largely nonconfined manner and might thus contribute to direct and collateral disturbance of electrical signaling in neurons. A major inflammatory cytokine of CD4 ϩ and CD8 ϩ T cells, INF-␥, was shown to induce neuronal excitotoxicity by intracellular trans-signaling between the INF-␥ receptor and a Ca 2ϩ -permeable neuronal AMPA/kainate receptor in the absence of extracellular glutamate (177) . TNF-␣, another major cytokine also secreted by proinflammatory T cells, is capable of inducing largely unselective, high-conductance ion channels following pH-dependent insertion into lipid bilayer or cell membranes (178 -180) . Other inflammatory mediators are also likely to contribute to the perturbation of neuronal excitability (reviewed in ref. 181 ).
Hence, all major effector pathways of cytotoxic CD8 ϩ T cells pronouncedly affect the electrical excitability of neurons. This might have functional consequences on a systemic level, e.g., conduction blocks or paroxysmal CNS symptoms in affected patients. On a cellular level, these short-term, immediate effects, in turn, influence the efficiency of MHC I-dependent antigen presentation and subsequent killing.
CONCLUSIONS
Cytotoxic MHC I-restricted CD8 ϩ T cells can either directly target neurons and their neurites or lead to collateral neuronal damage following destruction of the myelin sheath and ODCs or both in various inflammatory and degenerative disorders of CNS gray and white matter.
Here, we compiled available information on the role of CD8 ϩ T cells in various CNS disorders. Further, we have outlined different scenarios, how CNS-directed CD8 ϩ T-cell responses are generated, how CD8 ϩ T cells migrate within the CNS, and how they recognize their target structures. Finally, we sketched different possibilities of how CD8 ϩ T cells impair neuronal function and integrity in CNS gray and white matter.
CNS-antigen reactive CD8 ϩ T cells can be primed as a consequence of an initial destructive process within the CNS by cross-presenting CNS-related antigens in lymph nodes by professional antigen-presenting cells following CNS antigen-drainage. This may occur either passively with the CSF and lymphatics or after uptake by local APCs. Alternatively, naive CD8 ϩ T cells can be primed by peripheral stimuli and cross-recognize CNS antigen-epitopes by molecular mimicry/identity, activation of bystander CD8 ϩ T cells, intramolecular and intermolecular epitope spreading, and the presentation of cryptic antigens.
Primed CD8 ϩ T cells can enter the CNS after reencountering their antigen presented in the context of MHC I molecules expressed luminally on cerebral endothelial cells. Having entered an intact CNS parenchyma, CD8 T cells face a tonically immune-inhibitory environment. This is assumed to lack local antigen presentation and restimulation by microglia and is characterized by the virtual absence of MHC I expression on target cells. However, the presence of a proinflammatory milieu permits the functional up-regulation of MHC I expression, which is required for antigen presentation not only on neurons but also on every other cell type within the CNS. When entering the CNS, CD8
ϩ T cells are likely to display random-walk-like migration and start engaging in transient short-term interactions with potential target cells. After encountering target cells presenting their cognate antigen, CD8 ϩ T cells arrest to undergo stable long-term interactions, allowing for formation of the IS and exertion of cytotoxicity. The key mechanisms of CD8 ϩ T cell-mediated cytotoxicity are mediated via perforin-dependent delivery of several granzymes into the target cell or FasL-Fas interactions. The predominance of each pathway depends on the strength of the antigen signal delivery by the target cell. CD8 ϩ T-cell cytotoxicity can occur in the absence of a stable IS favoring the leakage of effector molecules out of the synaptic cleft into the surrounding space. Moreover, during sequential and simultaneous killing, a spatially nonconfined release of effector molecules is able to promote collateral cell death within the CNS.
Depending on the site of interaction, CD8 ϩ T cellneuron interactions result in either neuronal cell death and damage to dendrites in CNS gray mater or axonal damage in CNS white matter. Notably, in addition to the induction of neuronal cell death or axonal transection, effector molecules of CD8 ϩ T cells are capable of disturbing electrical signaling in excitable target and bystander cells, and this, in turn, likely affects efficiency of MHC I-dependent antigen-presentation and CD8 ϩ T cell killing, thereby promoting a self-amplifying loop of CD8 ϩ T-cell-mediated CNS tissue destruction. 
